{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-037858","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2024-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.960492+00:00","generated_at":"2026-05-31T02:11:03.678950+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Calidi Biotherapeutics elects Alan Stewart as director, ratifies auditor at annual meeting","bullets":["Quorum of 57.57% (4,641,839 shares) present at Sep 20, 2024 annual meeting.","Alan Stewart elected Class I director with 2,055,631 votes for; 2,586,208 abstentions, no against.","George Ng did not stand for re-election; Board reduced from 6 to 5 members, no vacancy.","Ratification of Marcum LLP as auditor passed with 4,547,883 for, 36,790 against, 57,166 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-037858","json":"https://secwatch.observer/filing/0001493152-24-037858.json","markdown":"https://secwatch.observer/filing/0001493152-24-037858.md","text":"https://secwatch.observer/filing/0001493152-24-037858.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224037858/0001493152-24-037858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224037858/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:11:03.678950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}